US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, h...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, ann...
Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
At an AbbVie-sponsored symposium at the ESMO Asia Congress 2025, experts gathered to address platinum resistance in adva...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Hong Kong-based Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibod...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
Nanyang Biologics (NYB) has entered into a business combination agreement (BCA) with RF Acquisition Corp II (RFAI), a pu...
Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US represent...
Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelera...
Nanyang Biologics (NYB) enters a strategic collaboration with NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to b...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials...
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...
HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader...
A*STAR and ETH Zürich have officially inked a Memorandum of Understanding (MOU) to deepen research collaboration in...
Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with US-based startup Jorna The...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medic...
Harvest Integrated Research Organization (HiRO), a boutique global CRO, has signed an Memorandum of Understanding (MoU) ...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...
LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...
What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...
Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...
Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...
Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a...
AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...
Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...
Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...
ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...
Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...
This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...
American pharmaceutical firm Eli Lilly and Company has announced a $4.5 billion investment to create the Lilly...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
Bridge Biotherapeutics, a startup based in the Republic of Korea and the US, has entered into a joint research agreement...
Advancements in Drug Delivery Technologies Innovative drug delivery systems have emerged to address the limitations of ...
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland&rsq...
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised ...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...
invoX Pharma, a UK-based research-driven global biopharmaceutical company with an advancing pipeline of innovative produ...
Japanese Foundation for Cancer Research (JFCR) and Takeda Pharmaceutical have signed a partnership agreement with the go...
Takeda Pharmaceutical, Astellas Pharma and Sumitomo Mitsui Banking Corporation (SMBC), in Japan, have signed a master ag...
German firm Boehringer Ingelheim and Japan-based Sosei Group Corporation have entered a global collaboration and exclusi...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...
Chugai Pharmaceutical has decided to position its research subsidiary in Singapore, Chugai Pharmabody Research...
Nikon Instruments Inc. has announced the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, US, ...
China-based startup Sanyou Biopharmaceuticals has officially announced the launch of its "Sanyou Super Trillion Pep...
Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with UK Dementia Research Institute (...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
Pharmaceutical 3D screen printing company Laxxon Medical has been selected alongside seven other high-potential companie...
Japan-based University of Tsukuba and Astellas Pharma have signed a letter of confirmation regarding a strateg...
Duke-NUS Medical School (Duke-NUS) in Singapore and IPGaia, Inc. (IPG) in Japan have signed an agreement to jointly adva...
Japan-based companies Fujitsu and TOPPAN Holdings Inc. have concluded a business alliance agreement to jointly promote t...
Fujitsu Limited and the High Performance Computing (HPC)- and AI-driven Drug Development Platform Division of the RIKEN ...
GlaxoSmithKline K.K. and National University Corporation Kyushu University have signed a strategic partnership agreement...
Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund, along with global li...
The life sciences industry is entering a digital renaissance. Organizations are increasingly exploring and investing in ...
PeptiDream Inc., a Japan-based biopharmaceutical company, has announced a new multi-target collaboration and license agr...
South Korea-based startup Standigm, a company using artificial intelligence (AI) technology for drug discovery and devel...
Japanese firms Chugai Pharmaceutical Co., and Omron Corporation are working together on the automation of research proce...
Rapid developments are taking place across the fields of artificial intelligence (AI) and biotechnology, and application...
The University of Sydney, Australia has signed a Memorandum of Understanding (MoU) with Pharos Therapeutics, the Austral...
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...
South Korea-based Avixgen is currently having a strong pipeline in ophthalmic diseases such as age related macular degen...
Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...
South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...
South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...
Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...
French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...
Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...
The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...
Genuv Inc., a clinical-stage biotechnology startup focused on drug discovery, and South Korea headquartred Celltrion, a ...
A company launched from Australia-based University of Queensland’s Institute for Molecular Bioscience (I...
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...
Hundreds of thousands of Australians with life-threatening high cholesterol are set to benefit from a revolutionary new ...
Japan-based pharmaceutical companies Teijin Limited and Axcelead, Inc. have jointly announced their basic agreemen...
